Optimal predialysis care

NDT Plus

Volumn 1, Issue SUPPL. 4, 2008, Pages

  Sijpkens, Yvo W J ^a   Berkhout Byrne, Noeleen C ^a   Rabelink, Ton J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chronic kidney disease; Pre emptive transplantation; Predialysis

Indexed keywords

CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERPHOSPHATEMIA; HYPERTENSION; HYPERURICEMIA; KIDNEY TRANSPLANTATION; METABOLIC DISORDER; NURSING CARE; OBESITY; PATIENT CARE; PRIORITY JOURNAL; PROTEINURIA; PSYCHOSOCIAL CARE; RENAL REPLACEMENT THERAPY; SMOKING;

EID: 57349159378     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfn117     Document Type: Conference Paper

References (34)

1. Pereira BJ. Optimization of pre-ESRD care: the key to improved dialysis outcomes. Kidney Int 2000; 57: 351-365
2. Jafar TH, Stark PC, Schmid CH et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level metaanalysis. Ann Intern Med 2003; 139: 244-252
3. Ozsoy RC, Van Der Steeg WA, Kastelein JJ et al. Dyslipidaemia as predictor of progressive renal failure and the impact of treatment with atorvastatin. Nephrol Dial Transplant 2007; 22: 1578-1586
4. Orth SR, Hallan SI. Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity andmortality in renal patients absence of evidence or evidence of absence? Clin J Am Soc Nephrol 2008; 3: 226-236
5. Kambham N, Markowitz GS, Valeri AM et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59: 1498-1509
6. Voormolen N, Noordzij M, Grootendorst DC et al. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 2007; 22: 2909-2916
7. Siu YP, Leung KT, Tong MK et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006; 47: 51-59
8. Bellizzi V, Di Iorio BR, De Nicola L et al. Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease. Kidney Int 2007; 71: 245-251
9. Uribarri J, Tuttle KR. Advanced glycation end products and nephrotoxicity of high-protein diets. Clin J Am Soc Nephrol 2006; 1: 1293-1299
10. Krediet RT. How to preserve residual renal function in patients with chronic kidney disease and on dialysis? Nephrol Dial Transplant 2006; 21(Suppl 2): ii42-ii46
11. Drueke TB, Locatelli F, Clyne N et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355: 2071-2084
12. Moe S, Drueke T, Cunningham J et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 69: 1945-1953
13. Hruska KA, Saab G, Mathew S et al. Renal osteodystrophy, phosphate homeostasis, and vascular calcification. Semin Dial 2007; 20: 309-315
14. Levin A, Bakris GL, Molitch M et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007; 71: 31-38
15. Al Aly Z, Qazi RA, Gonzalez EA et al. Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis 2007; 50: 59-68
16. Coyne D, Acharya M, Qiu P et al. Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4CKD. Am J Kidney Dis 2006; 47: 263-276
17. Kalantar-Zadeh K, Mehrotra R, Fouque D et al. Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure. Semin Dial 2004; 17: 455-465
18. Roderick P, Willis NS, Blakeley S et al. Correction of chronic metabolic acidosis for chronic kidney disease patients. Cochrane Database Syst Rev 2007; 1CD001890
19. Gennari FJ, Segal AS. Hyperkalemia: an adaptive response in chronic renal insufficiency. Kidney Int 2002; 62: 1-9
20. Johnson RJ, Segal MS, Srinivas T et al. Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link? J Am Soc Nephrol 2005; 16: 1909-1919
21. Van Praet JT, DeVriese AS. Prevention of contrast-induced nephropathy: a critical review. Curr Opin Nephrol Hypertens 2007; 16: 336-347
22. Penfield JG, Reilly RF Jr. What nephrologists need to know about gadolinium. Nat Clin Pract Nephrol 2007; 3: 654-668
23. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
24. Yilmaz MI, Carrero JJ, Axelsson J et al. Low-grade inflammation in chronic kidney disease patients before the start of renal replacement therapy: sources and consequences. Clin Nephrol 2007; 68: 1-9
25. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 116: 85-97
26. Van Zuilen AD, Wetzels JF, Blankestijn PJ et al. Rationale and design of the MASTERPLAN study: multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners. J Nephrol 2005; 18: 30-34
27. Meier-Kriesche HU, Schold JD. The impact of pretransplant dialysis on outcomes in renal transplantation. Semin Dial 2005; 18: 499-504
28. Lok CE, Oliver MJ. Overcoming barriers to arteriovenous fistula creation and use. Semin Dial 2003; 16: 189-196
29. Chambers J, Germain M, Brown E. 2004. Supportive Care for the Renal Patient. Oxford: Oxford University Press
30. Jungers P, Massy ZA, Nguyen-Khoa T et al. Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant 2001; 16: 2357-2364
31. Jungers P, Joly D, Nguyen-Khoa T et al. Continued late referral of patients with chronic kidney disease. Causes, consequences, and approaches to improvement. Presse Med 2006; 35: 17-22
32. Roderick P, Jones C, Tomson C et al. Late referral for dialysis: improving the management of chronic renal disease. QJM 2002; 95: 363-370
33. Winkelmayer WC, Owen WF Jr, Levin R et al. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol 2003; 14: 486-492
34. Keith DS, Nichols GA, Gullion CM et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663